Japan Lifeline Co., Ltd.

Equities

7575

JP3754500001

Medical Equipment, Supplies & Distribution

Delayed Japan Exchange Other stock markets 02:00:00 2024-06-27 EDT			5-day change	1st Jan Change
1,148 ^JPY	+1.68%		+5.71%	-9.11%

06-05	Japan Lifeline Completes 5.23 Billion Yen Share Acquisition via Tender Offer	MT
06-04	Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 1, 2024.	CI

Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 1, 2024.

June 04, 2024 at 02:10 am

From May 1, 2024 to June 3, 2024, the company has repurchased 5,000,100 shares, representing 6.67% for ¥5,225.1 million. With this, the company has completed the repurchase of 5,000,100 shares, representing 6.67% for ¥5,225.1 million under the buyback announced on May 1, 2024.

Latest news about Japan Lifeline Co., Ltd.

Japan Lifeline Completes 5.23 Billion Yen Share Acquisition via Tender Offer	06-04	MT
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 1, 2024.	06-04	CI
Japan Lifeline Co., Ltd.'s Equity Buyback announced on May 1, 2024 has closed with 5,000,100 shares, representing 6.67% for ¥5,225.1 million.	06-02	CI
Japan Lifeline Co., Ltd. Announces Executive Changes	05-23	CI
Japan Lifeline Co., Ltd. Proposes Dividend for the Fiscal Year Ended March 31, 2024	05-23	CI
Japan Lifeline's Attributable Profit Grows 9% in Fiscal Year Ended March	05-03	MT
Japan Lifeline to Launch Tender Offer for Treasury Shares	05-03	MT
Japan Lifeline to Dispose of 183 Million Yen Treasury Shares as Restricted Stock Compensation	05-03	MT
Japan Lifeline Co., Ltd. Provides Consolidated and Non-Consolidated Earnings Guidance for the Second Quarter End and Year Ending March 31, 2025	05-01	CI
Japan Lifeline Co., Ltd. Announces Year-End Cash Dividend for the Year Ended March 31, 2024, Payable on June 27, 2024; Provides Year-End Cash Dividend Guidance for the Fiscal Year Ending March 31, 2025	05-01	CI
Japan Lifeline Co., Ltd. announces an Equity Buyback for 5,500,100 shares, representing 7.34% for ¥5,747.6 million.	05-01	CI
Japan Lifeline Co., Ltd. authorizes a Buyback Plan.	04-30	CI
Japan Lifeline Completes Cancellation of 7.16 Million Shares	03-13	MT
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023.	03-01	CI
Japan Lifeline Co., Ltd.'s Equity Buyback announced on May 10, 2023, has closed with 3,000,000 shares, representing 3.9% for ¥3,319.77 million.	02-28	CI
Japan Lifeline Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024	02-02	CI
Japan Lifeline Co., Ltd. Announces the Appointment of Nobuo Takahashi as Operating Officer, Associate Executive Manager of CVG Business Unit	01-31	CI
Japanese Shares Return to Green on Upbeat Economic Data	01-05	MT
Japan Lifeline Buys Back Shares Worth Over 217 Million Yen	01-04	MT
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023.	01-04	CI
Japan Lifeline Buys Back 244,300 Shares for 272.88 Million Yen	12-04	MT
Japan Lifeline Co., Ltd. Announces Management Changes	12-01	CI
Japan Lifeline Raises Forecasts for Fiscal 2024 After Better than Expected First Half	11-07	MT
Japan Lifeline Co., Ltd. Revises Year End Dividend Guidance for the Fiscal Year 2024	11-06	CI
Japan Lifeline Co., Ltd. Revises Consolidated and Non-Consolidated Earnings Guidance for the Fiscal Year Ending 31, 2024	11-06	CI

Chart Japan Lifeline Co., Ltd.

Duration

Period

More charts

Company Profile

Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-30 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Japan Lifeline Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1,129 JPY

Average target price

1,369 JPY

Spread / Average Target

+21.24%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
JAPAN LIFELINE CO., LTD.	-9.11%	526M
STRYKER CORPORATION	+13.71%	130B
SMITH & NEPHEW PLC	-9.06%	10.77B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-15.31%	7.37B
GLAUKOS CORPORATION	+46.76%	5.87B
INSPIRE MEDICAL SYSTEMS, INC.	-32.21%	4.1B
AXONICS, INC.	+8.24%	3.44B
ENOVIS CORPORATION	-19.53%	2.47B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-17.06%	1.94B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-22.28%	1.72B

Medical Devices & Implants